BancFirst Corporation (BANF) capitalization

Current snapshot

Market Cap
$3.64B
33.6M shares × $108.50 · as of last filing 2026-03-31
Net Worth
$1.90B
Stockholders' equity · 2026-03-31
Enterprise Value
$3.66B
Market cap + debt − cash
Net Debt
$15.0M
Debt $15.0M − Cash —

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $3.59B
FY'24 2024-12-31 $3.94B
FY'23 2023-12-31 $3.26B
FY'22 2022-12-31 $2.95B
FY'21 2021-12-31 $2.35B
FY'20 2020-12-31 $1.95B
FY'19 2019-12-31 $2.08B
FY'18 2018-12-31 $1.67B
FY'17 2017-12-31 $1.67B
FY'16 2016-12-31 $2.96B
FY'15 2015-12-31 $1.86B
FY'14 2014-12-31 $1.00B
FY'13 2013-12-31 $871.7M
FY'12 2012-12-31 $654.2M
FY'11 2011-12-31 $583.8M
FY'11 2010-12-31 $644.7M
FY'11 2009-12-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $3.69B
Q4'25 2025-12-31 $3.56B
Q3'25 2025-09-30 $4.28B
Q2'25 2025-06-30 $4.18B
Q1'25 2025-03-31 $3.71B
Q4'24 2024-12-31 $3.89B
Q3'24 2024-09-30 $3.54B
Q2'24 2024-06-30 $2.94B
Q1'24 2024-03-31 $2.95B
Q4'23 2023-12-31 $3.21B
Q3'23 2023-09-30 $2.91B
Q2'23 2023-06-30 $3.08B
Q1'23 2023-03-31 $2.78B
Q4'22 2022-12-31 $2.90B
Q3'22 2022-09-30 $3.00B
Q2'22 2022-06-30 $3.20B
Q1'22 2022-03-31 $2.77B
Q4'21 2021-12-31 $2.30B
Q3'21 2021-09-30 $2.00B
Q2'21 2021-06-30 $2.09B
Q1'21 2021-03-31 $2.36B
Q4'20 2020-12-31 $1.92B
Q3'20 2020-09-30 $1.35B
Q2'20 2020-06-30 $1.34B
Q1'20 2020-03-31 $1.11B
Q4'19 2019-12-31 $2.04B
Q3'19 2019-09-30 $1.85B
Q2'19 2019-06-30 $1.85B
Q1'19 2019-03-31 $1.74B
Q4'18 2018-12-31 $1.63B
Q3'18 2018-09-30 $2.01B
Q2'18 2018-06-30 $1.98B
Q1'18 2018-03-31 $1.77B
Q4'17 2017-12-31 $1.63B
Q3'17 2017-09-30 $1.85B
Q2'17 2017-06-30 $3.14B
Q1'17 2017-03-31 $2.92B
Q4'16 2016-12-31 $2.94B
Q3'16 2016-09-30 $2.31B
Q2'16 2016-06-30 $955.6M
Q1'16 2016-03-31 $902.0M
Q4'15 2015-12-31 $1.83B
Q3'15 2015-09-30 $1.00B
Q2'15 2015-06-30 $1.04B
Q1'15 2015-03-31 $965.8M
Q4'14 2014-12-31 $982.8M
Q3'14 2014-09-30 $988.2M
Q2'14 2014-06-30 $980.0M
Q1'14 2014-03-31 $886.9M
Q4'13 2013-12-31 $859.6M
Q3'13 2013-09-30 $843.2M
Q2'13 2013-06-30 $720.6M
Q1'13 2013-03-31 $645.6M
Q4'12 2012-12-31 $645.7M
Q3'12 2012-09-30 $663.6M
Q2'12 2012-06-30 $646.5M
Q1'12 2012-03-31 $671.5M
Q4'11 2011-12-31 $567.5M
Q3'11 2011-09-30 $513.0M
Q2'11 2011-06-30 $604.2M
Q1'12 2011-03-31 $656.9M
Q4'11 2010-12-31 $633.0M
Q3'11 2010-09-30 $621.4M
Q2'11 2010-06-30 $560.0M

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (BANF CIK 0000760498), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

RS

RELIANCE, INC.

BCBP

BCB BANCORP INC

IBRX

IMMUNITYBIO, INC.